http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8176fd94a4900d31895196ef3368f0de
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Cross |
| name | Darren Cross |
| given-name | Darren |
| organization-name | Oncology iMED, AstraZeneca, Alderley Park, Cheshire SK10 4TG, U.K. 11AstraZeneca Pharmaceuticals, Cambridge, United Kingdom. AstraZeneca Oncology, Innovative Medicines, Alderley Park, Macclesfield, Cheshire, United Kingdom; AstraZeneca Oncology, Innovative Medicines, CRUK Cambridge Institute, Cambridge, United Kingdom 2iMED Oncology, AstraZeneca, Cambridge, United Kingdom. Oncology iMED AstraZeneca CRUK Cambridge Institute Cambridge UK Authors' Affiliations: 1Oncology iMED, 2Imaging, Personalized Healthcare and Biomarkers, AstraZeneca, Cheshire, United Kingdom; and 3Innovation Center China, AstraZeneca, Shanghai, China AstraZeneca plc, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K. 2Oncology Biosciences, AstraZeneca, Cambridge and Alderley Park, Macclesfield, United Kingdom. 8AstraZeneca Oncology, Cambridge, United Kingdom. |
Incoming Links
Total number of triples: 30.